Neurosonographic Findings of Vitamin D DeficiencyNCT06903247
Neurosonographic Findings in Pregnant Women With Vitamin D Deficiency
An observational study of Neurosonographic Findings of Vitamin D Deficiency, run by Sanliurfa Education and Research Hospital at 1 site in Turkey (Türkiye).
Trial summary
In the study, the potential effects of vitamin D deficiency on fetal neurodevelopmental parameters will be examined. In this context, fetal brain development will be compared between pregnant women with and without vitamin D deficiency, revealing the possible neurodevelopmental outcomes of vitamin D deficiency during… Read more about this study
- Who is it for?
- Ages 18 to 50 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Neurosonographic Findings of Vitamin D Deficiency
- What is being tested?
- Neurosonographic Findings of Vitamin D Deficiency in Single Healthy Pregnancies Presenting for Routine Antenatal Care Between 20-30 Weeks of Gestation.
- How many people
- 100 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Mar 2025to 30 Nov 2025
- How long will I take part?
- 4 Months
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: Patients presenting to the Perinatology clinic of Şanlıurfa Training and Research Hospital for routine antenatal care between 20-30 weeks of gestation will be included.
Inclusion Criteria:Patients presenting for routine antenatal care between 20-30 weeks of gestation will be included.
Exclusion Criteria:Multiple pregnancy, preterm rupture of membranes, chorioamnionitis, placental abruption, severe fetal growth restriction, congenital fetal anomalies, preeclampsia, oligohydramnios and maternal diabetes.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site
Sanliurfa Education and Research Hospital
Sanliurfa, 63100
About this study
Official title: Evaluation of Neurosonographic Findings in Pregnant Women With Vitamin D Deficiency
In the study, the potential effects of vitamin D deficiency on fetal neurodevelopmental parameters will be examined. In this context, fetal brain development will be compared between pregnant women with and without vitamin D deficiency, revealing the possible neurodevelopmental outcomes of vitamin D deficiency during the prenatal period.
Read the detailed description
Vitamin D is a vitamin that regulates calcium and phosphorus balance in the body and plays a crucial role in bone health. Additionally, it is known to have effects on immune system functions and neurological health. Pregnancy is a period in which vitamin D requirements increase, and vitamin D deficiency can lead to various health problems. It is believed that vitamin D deficiency may have adverse effects on fetal neurological development and may be associated with certain pathological conditions during pregnancy.
Neurosonography is a critical tool for assessing the effects of prematurity, vitamin D deficiency, and other pregnancy complications on the fetus. This article will focus on the evaluation of neurosonographic findings in pregnant women with vitamin D deficiency.
- Being tested
- Neurosonographic Findings of Vitamin D Deficiency in Single Healthy Pregnancies Presenting for Routine Antenatal Care Between 20-30 Weeks of Gestation.
- Keywords
- Neurosonography Vitamin D Deficiency Pregnancy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Neurosonographic Findings of Vitamin D Deficiency in Single Healthy Pregnancies Presenting for Routine Antenatal Care Between 20-30 Weeks of Gestation.Other
Comparison of Neurosonographic Findings in Patients with and without Vitamin D Deficiency.
| Study group | Role | What they receive |
|---|---|---|
| Pregnant women with vitamin D deficiency who present for routine antenatal care between 20-30 weeks | Not described Receives: Other: Neurosonographic Findings of Vitamin D Deficiency in Single Healthy Pregnancies Presenting for Routine Antenatal Care Between 20-30 Weeks of Gestation. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pregnant women with vitamin D deficiency who present for routine antenatal care between 20-30 weeks of gestation.
Measured: Neurosonogram Results Performed Between 20-30 Weeks of Gestation.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Mar 2025
- Study start15 Mar 2025
- Primary completion30 Jun 2025
- Study completion30 Nov 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Neurosonographic Findings of Vitamin D DeficiencyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
- Target duration
- 4 Months
Sponsor and investigators
- Lead sponsor
- Sanliurfa Education and Research Hospital
- Sponsor type
- Other government
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06903247
- Sponsor's protocol ID
- ŞEAH-DVİT-NORO
- Status last verified
- Nov 2025
- First submitted
- 24 Mar 2025
- Last updated
- 18 Nov 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Neurosonographic Findings in Pregnant Women With Vitamin D Deficiency
- ClinicalTrials.gov ID
- NCT06903247
- Acronym / sponsor ID
- ŞEAH-DVİT-NORO
- Keywords
- Neurosonography Vitamin D Deficiency Pregnancy
- Study type
- Observational
- Recruitment status
- Enrolling by invitation
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Sanliurfa Education and Research HospitalOther government
- Study start
- 15 Mar 2025 (actual)
- Primary completion
- 30 Jun 2025 (actual)
- Study completion
- 30 Nov 2025 (estimated)
- First posted
- 30 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In the study, the potential effects of vitamin D deficiency on fetal neurodevelopmental parameters will be examined. In this context, fetal brain development will be compared between pregnant women with and without vitamin D deficiency, revealing the possible neurodevelopmental outcomes of vitamin D deficiency during the prenatal period.
Detailed description
Vitamin D is a vitamin that regulates calcium and phosphorus balance in the body and plays a crucial role in bone health. Additionally, it is known to have effects on immune system functions and neurological health. Pregnancy is a period in which vitamin D requirements increase, and vitamin D deficiency can lead to various health problems. It is believed that vitamin D deficiency may have adverse effects on fetal neurological development and may be associated with certain pathological conditions during pregnancy.
Neurosonography is a critical tool for assessing the effects of prematurity, vitamin D deficiency, and other pregnancy complications on the fetus. This article will focus on the evaluation of neurosonographic findings in pregnant women with vitamin D deficiency.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Target follow-up
- 4 Months
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Pregnant women with vitamin D deficiency who present for routine antenatal care between 20-30 weeks | – | Other: Neurosonographic Findings of Vitamin D Deficiency in Single Healthy Pregnancies Presenting for Routine Antenatal Care Between 20-30 Weeks of Gestation. |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Patients presenting to the Perinatology clinic of Şanlıurfa Training and Research Hospital for routine antenatal care between 20-30 weeks of gestation will be included.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Neurosonographic Findings of Vitamin D Deficiency in Single Healthy Pregnancies Presenting for Routine Antenatal Care Between 20-30 Weeks of Gestation.Comparison of Neurosonographic Findings in Patients with and without Vitamin D Deficiency. | Other | Pregnant women with vitamin D deficiency who present for routine antenatal care between 20-30 weeks |
Primary outcome
Pregnant women with vitamin D deficiency who present for routine antenatal care between 20-30 weeks of gestation.
Time frame: Neurosonogram Results Performed Between 20-30 Weeks of Gestation.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Nov 2025.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Neurosonographic Findings of Vitamin D Deficiency, run by Sanliurfa Education and Research Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 18 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pregnant women with vitamin D deficiency who present for routine antenatal care between 20-30 weeks of gestation. (time frame: Neurosonogram Results Performed Between 20-30 Weeks of Gestation.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2025.